Скачать или смотреть Metabolic Autism Prediction (MAP) Study - John Slattery, BioROSA Technologies @Synchrony2021

An update on the ongoing clinical trial for metabolic prediction of autism using BioROSA developed laboratory methods.

Prior to founding BioROSA, John Slattery worked in academia doing ASD clinical and translational research at Arkansas Children’s Hospital from 2010-2017 with Drs. Richard Frye, Jill James, Stephen Kahler, Shannon Rose, and others. As a part of a multidisciplinary autism research group focused on novel therapeutic strategies for ASD, along with biomarker discovery work on putative etiological and pathophysiological factors underlying ASD, John was involved in over 35 highly cited peer reviewed articles on ASD dedicated to this work. The ACH team's most significant achievement at the time was conducting one of the only positive Phase 2 clinical trials that investigated a novel intervention in autism which was billed "the first positive precision medicine initiative in neuropsychiatry".

John has extensive ties to the autism clinical, research, and patient community and a wide knowledge base of ASD from a clinical, scientific, and business perspective. At ACH John was the personnel manager for the autism program and managed a team of 10 and was the director of autism translational research under Dr. Richard Frye, MD/PhD. John joined a software startup company in 2017 where he was in charge of sales and R&D. Prior to that he worked at UPenn doing brain imaging research from 2007-2010. John has a BA from the University of Arkansas and has multiple certifications in clinical research.

#biology #biomarkers #earlydiagnosis #earlytreatment #metabolic #diagnostics


🎥 This talk was part of Synchrony 2021 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech.

🎥 For more Synchrony 2021 talks and highlights:
   • Synchrony Symposium 2021 - From Bench To B...  


🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder.

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care.

To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.